万东医疗: 万东医疗关于以集中竞价交易方式回购股份的进展公告

Group 1 - The company announced a share repurchase plan with a total expected amount between 30 million and 60 million RMB [1] - The repurchase will be conducted through centralized bidding and is intended for employee stock ownership plans or equity incentives [1] - The repurchase period is set from August 22, 2025, to August 21, 2026, with a maximum repurchase price of 25 RMB per share [1] Group 2 - As of August 28, 2025, the company has opened a dedicated account for the share repurchase and is in the process of setting up corresponding financial accounts [2] - The company will make repurchase decisions based on market conditions and will fulfill information disclosure obligations in a timely manner [2]